Concourse Financial Group Securities, Inc. Nls Pharmaceutics Ltd. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024
BUY
$0.11 - $0.27 $0 - $0
0 New
0 $0
Q1 2024

Apr 30, 2024
BUY
$0.16 - $0.59 $0 - $0
0 New
0 $0
Q4 2023

Feb 07, 2024
BUY
$0.32 - $0.87 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
$0.7 - $1.42 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$0.7 - $1.42 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$0.92 - $1.56 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$1.26 - $1.82 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.48 - $1.29 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.34 - $1.12 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.53 - $1.36 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$0.82 - $1.76 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$1.11 - $2.56 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$2.29 - $3.14 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$2.91 - $4.12 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$2.28 - $5.85 $0 - $0
0 New
0 $0

About NLS Pharmaceutics Ltd.

NLSP Quotes by TradingView
  • Ticker NLSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,349,900
  • Market Cap $55.5M
  • Description
  • NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...
More about NLSP
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email